Enablex FDA Approval History
FDA Approved: Yes (First approved December 22, 2004)
Brand name: Enablex
Generic name: darifenacin
Dosage form: Extended-Release Tablets
Company: Allergan plc
Treatment for: Overactive Bladder
Enablex (darifenacin) is a muscarinic receptor antagonist indicated for the treatment of overactive bladder.
Development timeline for Enablex
|Dec 22, 2004||Approval Enablex Novartis Pharmaceuticals Corporation - Treatment for Overactive Bladder|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.